You’ve likely seen the names Descovy and Biktarvy mentioned together when researching HIV care medications. 

They’re both small, once-a-day pills made by the same company, and they even share some of the same active ingredients.

But these two medications are used differently in HIV care. Descovy is most commonly used for HIV prevention, while Biktarvy is used for HIV treatment.

Descovy can also be used for HIV treatment, but must be combined with other medications. Biktarvy contains all the necessary components for HIV treatment in a single regimen, and may also be used in certain post-exposure (PEP) situations depending on clinical guidance.

Here is the breakdown of why they get confused, how they differ, and which one actually applies to your health goals.

Why these medications are sometimes confused — and the most important difference 

Both Descovy and Biktarvy are antiretrovirals, meaning they work by stopping HIV from making copies of itself. 

Biktarvy is built on the same foundation as Descovy, but it includes an additional drug called Bictegravir. That extra ingredient changes how the medication works — and ultimately what it’s used for.

  • Descovy is most commonly used for HIV prevention (PrEP): If you’re HIV-negative, Descovy helps reduce the risk of HIV infection by building protective drug levels in your body. It can also be used as part of HIV treatment, but must be combined with other medications.
  • Biktarvy is used for HIV treatment: If you’re living with HIV, taking Biktarvy lowers the HIV in your body to undetectable levels. This keeps your immune system strong and prevents the virus from being passed to sexual partners.

Where Descovy fits in HIV prevention and treatment

Descovy is most commonly used as oral PrEP (pre-exposure prophylaxis). The goal is simple: help people who are HIV-negative stay HIV-negative.

When taken daily, Descovy maintains a consistent level of medication in your system, helping prevent HIV from establishing infection.

  • Who can take it: Descovy is FDA-approved for gay and bisexual men, transgender women, and other individuals at risk of HIV through rectal sex.
  • Why daily dosing matters: Unlike emergency pills (like PEP) that you take after a potential exposure, PrEP needs to be in your system before anything happens. That’s why it’s taken once a day, every day (and why missed doses lower your protection).
  • Where it fits in HIV treatment: Descovy may be included as part of certain HIV treatment regimens, but it’s just one piece of the puzzle. On its own, it won’t fully control the virus — you need a full combo to keep HIV in check.

A note on vaginal exposure: Large clinical studies did not include sufficient data for individuals at risk through vaginal exposure, so it is not FDA approved for that use.

Where Biktarvy fits in HIV treatment

Biktarvy is a complete, all-in-one treatment for people living with HIV. Unlike Descovy (which is most commonly used for HIV prevention), Biktarvy’s goal is viral suppression. 

Taken consistently, it lowers HIV levels in your blood to undetectable levels, so your immune system stays strong and the virus can’t be passed to sexual partners.

  • Who can take it: Biktarvy is FDA-approved for adults and children living with HIV. It works for people starting treatment, switching from another regimen, or those who’ve taken meds before but aren’t fully suppressed yet.
  • Why daily dosing matters: Just like with PrEP, consistency is the key to success. Taking one pill every day keeps medication levels high enough in your body to suppress the virus. 
  • Where it fits in HIV treatment: It’s a single “3-in-1” pill that combines three medications (Emtricitabine, TAF, and Bictegravir) into one daily tablet. The first two ingredients block HIV from getting started, while the third hits it later — stopping the virus from copying itself.
  • The "one-pill" advantage: Before Biktarvy, managing HIV often required taking multiple medications every day. This all-in-one pill makes life simpler and makes it easier to stick to your treatment plan.

Why Biktarvy and Descovy are used differently

These medications are used for different primary purposes. Descovy is most commonly used for HIV prevention, though it can also be part of treatment in combination with other medications. 

Biktarvy is used as a complete HIV treatment regimen and may also be used in certain PEP situations depending on clinical guidance.

How clinicians decide which medication is appropriate

Picking the right antiretroviral depends on your health, your routine, and what fits your life. Doctors usually consider a few key things before deciding the best plan for you:

  • Your HIV status: This is the baseline. PrEP medications like Descovy are used for people who are HIV-negative. If your status is positive, the conversation shifts immediately to picking a treatment regimen designed to reach and maintain viral suppression (like Biktarvy).
  • Your medical history: Your provider has to look at the big picture. This includes checking your kidney health and reviewing any other medications you’re on to make sure there aren’t any risky interactions.
  • Long-term care planning: Your status determines whether you need a prevention regimen (PrEP) or a treatment regimen, but your options don’t stop there. Your clinician will help you decide which delivery method fits your lifestyle, your insurance, and your routine. Whether that’s daily PrEP pills, monthly injections, or even twice-yearly PrEP options, the goal is to find an option you can realistically stick to.

Frequently asked questions (FAQs)

It’s totally normal to have questions when you’re looking at these two medications. Here are the answers to the most common ones we hear:

Is Descovy the same as Biktarvy?

No. These medications are not interchangeable. While Descovy and Biktarvy share two main ingredients, Biktarvy adds a third drug that makes it a full HIV treatment. Using one in place of the other is not clinically appropriate, so it’s always best to stick to what your provider prescribes.

Can Biktarvy be used for PrEP?

Short answer: no. Biktarvy is not approved for ongoing HIV prevention (PrEP), though it may be used as Post-Exposure Prophylaxis (PEP) in certain situations. 

What is Descovy used for?

Descovy is most commonly used as PrEP to reduce the risk of HIV infection in HIV-negative people. It can also appear as one piece of a larger HIV treatment regimen. 

Which medication prevents HIV?

Descovy is an FDA-approved medication for daily PrEP, which is designed to prevent HIV. 

Can I switch from Biktarvy to Descovy? 

Only in specific clinical situations. Biktarvy is a full HIV treatment. Descovy on its own is not. If you were taking Biktarvy as part of a 28‑day PEP (post‑exposure prophylaxis) course after a possible exposure and your final HIV test comes back negative, a clinician might switch you to Descovy (or another PrEP regimen) to continue prevention long term.

But if you’re living with HIV, you don’t “step down” to Descovy because it isn’t a complete treatment. That wouldn’t fully suppress the virus, and you need a full treatment regimen (like Biktarvy) to stay healthy.

Why can't I use Descovy for vaginal sex? 

Clinical trials did not include sufficient data for individuals at risk through vaginal exposure, so it is not FDA approved for that use. One recent study suggests that Descovy for PrEP in cis women is safe and effective but this has not changed approved indications for it use.

Looking for HIV prevention options?

Whether you're curious about PrEP or looking for a more personalized HIV prevention plan, our clinicians are here to help. We’ll break down your options, answer your questions, and help you decide what works best for your body and your lifestyle. The right protection is out there — let's help you find it.